We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News   May 17, 2018 | Original story from Sartorius

 
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

ambr® 250 bioreactor system

 
 
 

RELATED ARTICLES

Fighting the Good Fight

News

Blocking an important enzyme in staphylococcal metabolism in a targeted manner would allow the pathogens to be starved.

READ MORE

Inflammation-blocking Inhibitor Could Treat Sepsis Too

News

A new inhibitor which decreases lung inflammation could hold the key to treating Acute Respiratory Distress Syndrome and sepsis.

READ MORE

AI Predicts Treatment Effectiveness

News

A new AI method developed by Finnish researchers now provides answers about treatment effectiveness. Using modelling, the method makes it possible to compare different treatment alternatives and to identify patients who will benefit from treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE